Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical significance of gene polymorphisms for hereditary predisposition to breast and ovarian cancer (review of literature).

Klinicheskaia laboratornaia diagnostika·2022

Same author

[MODERN CLINICAL EPIDEMIOLOGICAL CHARACTERISTIC OF LUPUS ERYTHEMATOSUS BASED ON THE DATA OF REGIONAL REGISTRY].

Klinicheskaia meditsina·2018

Same author

[About reduodenization of digestive tract in gastrectomy].

Khirurgiia·2017

Same author

[Anatomico-morphological justification of nerve-sparing lymphodissection for breast cancer].

Khirurgiia·2017

Same author

[Functional results of digestive tract reconstruction after gastrectomy].

Khirurgiia·2017

Same author

[Survival rate after D3-lymphadenectomy for right-sided colic cancer: case-match study].

Khirurgiia·2016

Search research articles

Related Experiment Video

Updated: Mar 24, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

[Spleen-preserving D2 lymphodissection in gastrectomy].

V V Oleksenko¹, S V Efetov², K A Aliev¹

¹Chair of Oncology, S.I. Georgievskiy Crimean State Medical University, Simferopol.

|March 16, 2016

Summary

Spleen-preserving D2 lymphodissection in gastric cancer surgery is as effective as standard D2 lymphodissection with splenectomy. This approach reduces postoperative complications while maintaining similar survival rates for patients.

More Related Videos

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment

Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment

Published on: December 27, 2024

Related Experiment Videos

Last Updated: Mar 24, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment

Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment

Published on: December 27, 2024

Area of Science:

Surgical Oncology
Gastrointestinal Surgery
Gastric Cancer Treatment

Context:

Gastric cancer necessitates aggressive surgical intervention, often involving extensive lymph node dissection.
Total gastrectomy is a common procedure for advanced gastric cancer.
The role of splenectomy in D2 lymphodissection for gastric cancer remains a subject of debate regarding its impact on outcomes and complications.

Purpose:

To compare the immediate and long-term outcomes of spleen-preserving D2 lymphodissection versus standard D2 lymphodissection with splenectomy in patients undergoing total gastrectomy for gastric cancer.
To evaluate the oncological effectiveness and safety profile of spleen-preserving D2 lymphodissection.

Summary:

A study of 480 gastric cancer patients undergoing total gastrectomy compared spleen-preserving D2 lymphodissection (371 patients) with standard D2 lymphodissection plus splenectomy (109 patients).
Spleen-preserving D2 lymphodissection showed comparable 5-year survival (40.3% vs. 33.1%) and average life expectancy (3.4 vs. 2.7 years).
The spleen-preserving technique resulted in a similar incidence of postoperative complications (6.7% vs. 4.6%) and mortality rates (2.7% vs. 0.9%) compared to splenectomy, with no significant difference in the number of retrieved lymph nodes or detection of metastases in key splenic regions.

Impact:

Spleen-preserving D2 lymphodissection is a viable and potentially less morbid alternative to standard D2 lymphodissection with splenectomy for gastric cancer.
This surgical approach may lead to improved patient recovery and reduced complications without compromising oncological safety.
Findings support the adoption of spleen-preserving techniques in gastric cancer surgery, enhancing patient quality of life post-operation.